Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindol
- 1 July 1992
- journal article
- Published by Elsevier in Neuroscience
- Vol. 49 (2) , 317-327
- https://doi.org/10.1016/0306-4522(92)90099-n
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamenNeurobiology of Aging, 1989
- Postmortem analysis of adrenal–medulla–to–caudate autograft in a patient with parkinson's diseaseAnnals of Neurology, 1989
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophreniaSynapse, 1988
- Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatumAnnals of Neurology, 1987
- [3H]GBR-12935 Binding to the Dopamine Transporter Is Decreased in the Caudate Nucleus in Parkinson's DiseaseJournal of Neurochemistry, 1987
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987
- The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brainNeurochemistry International, 1987
- Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markersAnnals of Neurology, 1985
- Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake SitesJournal of Neurochemistry, 1983